ArticleThe journal of allergy and clinical immunology. In practice2024

PI3Kδ Pathway Dysregulation and Unique Features of Its Inhibition by Leniolisib in Activated PI3Kδ Syndrome and Beyond.

Andrew J Cant et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.